nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Ticagrelor—coronary artery disease	0.0575	0.085	CbGbCtD
Ergonovine—ABCB1—Clopidogrel—coronary artery disease	0.0355	0.0525	CbGbCtD
Ergonovine—ABCB1—Perindopril—coronary artery disease	0.0355	0.0525	CbGbCtD
Ergonovine—CYP3A4—Ticagrelor—coronary artery disease	0.0345	0.0509	CbGbCtD
Ergonovine—ABCB1—Telmisartan—coronary artery disease	0.0311	0.0459	CbGbCtD
Ergonovine—ABCB1—Pitavastatin—coronary artery disease	0.0311	0.0459	CbGbCtD
Ergonovine—CYP3A4—Fenofibrate—coronary artery disease	0.0307	0.0454	CbGbCtD
Ergonovine—ABCB1—Lisinopril—coronary artery disease	0.0294	0.0435	CbGbCtD
Ergonovine—ABCB1—Enalapril—coronary artery disease	0.0294	0.0435	CbGbCtD
Ergonovine—ABCB1—Timolol—coronary artery disease	0.025	0.037	CbGbCtD
Ergonovine—CYP3A4—Gemfibrozil—coronary artery disease	0.0246	0.0363	CbGbCtD
Ergonovine—ABCB1—Ezetimibe—coronary artery disease	0.0229	0.0338	CbGbCtD
Ergonovine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0223	0.033	CbGbCtD
Ergonovine—ABCB1—Captopril—coronary artery disease	0.022	0.0326	CbGbCtD
Ergonovine—CYP3A4—Clopidogrel—coronary artery disease	0.0213	0.0315	CbGbCtD
Ergonovine—ABCB1—Simvastatin—coronary artery disease	0.0213	0.0315	CbGbCtD
Ergonovine—ABCB1—Pravastatin—coronary artery disease	0.0208	0.0308	CbGbCtD
Ergonovine—ABCB1—Lovastatin—coronary artery disease	0.0208	0.0308	CbGbCtD
Ergonovine—CYP3A4—Eplerenone—coronary artery disease	0.0198	0.0292	CbGbCtD
Ergonovine—ABCB1—Atorvastatin—coronary artery disease	0.019	0.028	CbGbCtD
Ergonovine—CYP3A4—Enalapril—coronary artery disease	0.0176	0.0261	CbGbCtD
Ergonovine—ABCB1—Losartan—coronary artery disease	0.0174	0.0256	CbGbCtD
Ergonovine—CYP3A4—Ezetimibe—coronary artery disease	0.0137	0.0203	CbGbCtD
Ergonovine—CYP3A4—Rosuvastatin—coronary artery disease	0.0137	0.0203	CbGbCtD
Ergonovine—CYP3A4—Simvastatin—coronary artery disease	0.0128	0.0188	CbGbCtD
Ergonovine—CYP3A4—Lovastatin—coronary artery disease	0.0125	0.0184	CbGbCtD
Ergonovine—CYP3A4—Pravastatin—coronary artery disease	0.0125	0.0184	CbGbCtD
Ergonovine—CYP3A4—Atorvastatin—coronary artery disease	0.0114	0.0168	CbGbCtD
Ergonovine—CYP3A4—Losartan—coronary artery disease	0.0104	0.0154	CbGbCtD
Ergonovine—Methysergide—HTR7—coronary artery disease	0.000771	0.172	CrCbGaD
Ergonovine—Bromocriptine—HTR7—coronary artery disease	0.000574	0.128	CrCbGaD
Ergonovine—Lisuride—ADRB1—coronary artery disease	0.000531	0.119	CrCbGaD
Ergonovine—Bromocriptine—ADRB1—coronary artery disease	0.000492	0.11	CrCbGaD
Ergonovine—Methylergometrine—HTR2A—coronary artery disease	0.000465	0.104	CrCbGaD
Ergonovine—Methysergide—HTR2A—coronary artery disease	0.000388	0.0866	CrCbGaD
Ergonovine—Palpitations—Enalapril—coronary artery disease	0.000382	0.0019	CcSEcCtD
Ergonovine—Chest pain—Pravastatin—coronary artery disease	0.000381	0.00189	CcSEcCtD
Ergonovine—Dyspnoea—Ezetimibe—coronary artery disease	0.000377	0.00188	CcSEcCtD
Ergonovine—Palpitations—Telmisartan—coronary artery disease	0.000377	0.00187	CcSEcCtD
Ergonovine—Muscle spasms—Furosemide—coronary artery disease	0.000376	0.00187	CcSEcCtD
Ergonovine—Shock—Valsartan—coronary artery disease	0.000375	0.00187	CcSEcCtD
Ergonovine—Dizziness—Ticagrelor—coronary artery disease	0.000374	0.00186	CcSEcCtD
Ergonovine—Shock—Olmesartan—coronary artery disease	0.000373	0.00186	CcSEcCtD
Ergonovine—Acute coronary syndrome—Lisinopril—coronary artery disease	0.000371	0.00184	CcSEcCtD
Ergonovine—Bradycardia—Timolol—coronary artery disease	0.00037	0.00184	CcSEcCtD
Ergonovine—Chest pain—Trandolapril—coronary artery disease	0.00037	0.00184	CcSEcCtD
Ergonovine—Dyspnoea—Eplerenone—coronary artery disease	0.000369	0.00184	CcSEcCtD
Ergonovine—Myocardial infarction—Lisinopril—coronary artery disease	0.000369	0.00183	CcSEcCtD
Ergonovine—Hypertension—Telmisartan—coronary artery disease	0.000368	0.00183	CcSEcCtD
Ergonovine—Vomiting—Gemfibrozil—coronary artery disease	0.000368	0.00183	CcSEcCtD
Ergonovine—Chest pain—Enalapril—coronary artery disease	0.000368	0.00183	CcSEcCtD
Ergonovine—Hyperhidrosis—Olmesartan—coronary artery disease	0.000367	0.00182	CcSEcCtD
Ergonovine—Palpitations—Captopril—coronary artery disease	0.000367	0.00182	CcSEcCtD
Ergonovine—Shock—Niacin—coronary artery disease	0.000365	0.00181	CcSEcCtD
Ergonovine—Muscle spasms—Losartan—coronary artery disease	0.000363	0.00181	CcSEcCtD
Ergonovine—Chest pain—Telmisartan—coronary artery disease	0.000363	0.00181	CcSEcCtD
Ergonovine—Headache—Gemfibrozil—coronary artery disease	0.000363	0.0018	CcSEcCtD
Ergonovine—Hallucination—Timolol—coronary artery disease	0.000362	0.0018	CcSEcCtD
Ergonovine—Vertigo—Perindopril—coronary artery disease	0.000362	0.0018	CcSEcCtD
Ergonovine—Gastrointestinal pain—Fenofibrate—coronary artery disease	0.000361	0.0018	CcSEcCtD
Ergonovine—Sweating—Lisinopril—coronary artery disease	0.00036	0.00179	CcSEcCtD
Ergonovine—Dyspnoea—Simvastatin—coronary artery disease	0.00036	0.00179	CcSEcCtD
Ergonovine—Vomiting—Ticagrelor—coronary artery disease	0.00036	0.00179	CcSEcCtD
Ergonovine—Pergolide—HTR2A—coronary artery disease	0.000359	0.0802	CrCbGaD
Ergonovine—Haematuria—Lisinopril—coronary artery disease	0.000358	0.00178	CcSEcCtD
Ergonovine—Hyperhidrosis—Niacin—coronary artery disease	0.000358	0.00178	CcSEcCtD
Ergonovine—Hypotension—Valsartan—coronary artery disease	0.000356	0.00177	CcSEcCtD
Ergonovine—Palpitations—Perindopril—coronary artery disease	0.000356	0.00177	CcSEcCtD
Ergonovine—Gastrointestinal pain—Clopidogrel—coronary artery disease	0.000355	0.00177	CcSEcCtD
Ergonovine—Hypotension—Olmesartan—coronary artery disease	0.000355	0.00176	CcSEcCtD
Ergonovine—Headache—Ticagrelor—coronary artery disease	0.000354	0.00176	CcSEcCtD
Ergonovine—Chest pain—Captopril—coronary artery disease	0.000353	0.00176	CcSEcCtD
Ergonovine—Gastrointestinal pain—Lovastatin—coronary artery disease	0.000353	0.00176	CcSEcCtD
Ergonovine—Hyperhidrosis—Pravastatin—coronary artery disease	0.000353	0.00175	CcSEcCtD
Ergonovine—Vertigo—Furosemide—coronary artery disease	0.000352	0.00175	CcSEcCtD
Ergonovine—Abdominal pain—Fenofibrate—coronary artery disease	0.000349	0.00174	CcSEcCtD
Ergonovine—Shock—Trandolapril—coronary artery disease	0.000349	0.00173	CcSEcCtD
Ergonovine—Diarrhoea—Rosuvastatin—coronary artery disease	0.000348	0.00173	CcSEcCtD
Ergonovine—Hypertension—Perindopril—coronary artery disease	0.000348	0.00173	CcSEcCtD
Ergonovine—Shock—Enalapril—coronary artery disease	0.000347	0.00173	CcSEcCtD
Ergonovine—Tinnitus—Ramipril—coronary artery disease	0.000347	0.00173	CcSEcCtD
Ergonovine—Hypotension—Niacin—coronary artery disease	0.000346	0.00172	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ezetimibe—coronary artery disease	0.000346	0.00172	CcSEcCtD
Ergonovine—Nausea—Gemfibrozil—coronary artery disease	0.000344	0.00171	CcSEcCtD
Ergonovine—Bradycardia—Lisinopril—coronary artery disease	0.000344	0.00171	CcSEcCtD
Ergonovine—Abdominal pain—Clopidogrel—coronary artery disease	0.000344	0.00171	CcSEcCtD
Ergonovine—Chest pain—Perindopril—coronary artery disease	0.000343	0.00171	CcSEcCtD
Ergonovine—Hyperhidrosis—Trandolapril—coronary artery disease	0.000343	0.0017	CcSEcCtD
Ergonovine—Shock—Telmisartan—coronary artery disease	0.000343	0.0017	CcSEcCtD
Ergonovine—Hyperhidrosis—Enalapril—coronary artery disease	0.000341	0.0017	CcSEcCtD
Ergonovine—Abdominal pain—Lovastatin—coronary artery disease	0.000341	0.0017	CcSEcCtD
Ergonovine—Dyspnoea—Valsartan—coronary artery disease	0.00034	0.00169	CcSEcCtD
Ergonovine—Vertigo—Losartan—coronary artery disease	0.000339	0.00169	CcSEcCtD
Ergonovine—Tinnitus—Timolol—coronary artery disease	0.000339	0.00169	CcSEcCtD
Ergonovine—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000339	0.00168	CcSEcCtD
Ergonovine—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000339	0.00168	CcSEcCtD
Ergonovine—Dizziness—Rosuvastatin—coronary artery disease	0.000337	0.00167	CcSEcCtD
Ergonovine—Hyperhidrosis—Telmisartan—coronary artery disease	0.000337	0.00167	CcSEcCtD
Ergonovine—Nausea—Ticagrelor—coronary artery disease	0.000336	0.00167	CcSEcCtD
Ergonovine—Hallucination—Lisinopril—coronary artery disease	0.000336	0.00167	CcSEcCtD
Ergonovine—Abdominal pain—Ezetimibe—coronary artery disease	0.000335	0.00166	CcSEcCtD
Ergonovine—Palpitations—Losartan—coronary artery disease	0.000334	0.00166	CcSEcCtD
Ergonovine—Shock—Captopril—coronary artery disease	0.000333	0.00166	CcSEcCtD
Ergonovine—Hypotension—Trandolapril—coronary artery disease	0.000331	0.00165	CcSEcCtD
Ergonovine—Dyspnoea—Niacin—coronary artery disease	0.000331	0.00164	CcSEcCtD
Ergonovine—Gastrointestinal pain—Simvastatin—coronary artery disease	0.00033	0.00164	CcSEcCtD
Ergonovine—Hypotension—Enalapril—coronary artery disease	0.00033	0.00164	CcSEcCtD
Ergonovine—Abdominal pain—Eplerenone—coronary artery disease	0.000328	0.00163	CcSEcCtD
Ergonovine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000327	0.00163	CcSEcCtD
Ergonovine—Dyspnoea—Pravastatin—coronary artery disease	0.000325	0.00162	CcSEcCtD
Ergonovine—Hypotension—Telmisartan—coronary artery disease	0.000325	0.00162	CcSEcCtD
Ergonovine—Shock—Perindopril—coronary artery disease	0.000323	0.00161	CcSEcCtD
Ergonovine—Chest pain—Losartan—coronary artery disease	0.000322	0.0016	CcSEcCtD
Ergonovine—Abdominal pain—Simvastatin—coronary artery disease	0.000319	0.00159	CcSEcCtD
Ergonovine—Headache—Rosuvastatin—coronary artery disease	0.000319	0.00159	CcSEcCtD
Ergonovine—Hyperhidrosis—Perindopril—coronary artery disease	0.000318	0.00158	CcSEcCtD
Ergonovine—Hypotension—Captopril—coronary artery disease	0.000316	0.00157	CcSEcCtD
Ergonovine—Dyspnoea—Trandolapril—coronary artery disease	0.000316	0.00157	CcSEcCtD
Ergonovine—Dyspnoea—Enalapril—coronary artery disease	0.000315	0.00157	CcSEcCtD
Ergonovine—Tinnitus—Lisinopril—coronary artery disease	0.000315	0.00156	CcSEcCtD
Ergonovine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000315	0.00156	CcSEcCtD
Ergonovine—Shock—Furosemide—coronary artery disease	0.000314	0.00156	CcSEcCtD
Ergonovine—Gastrointestinal pain—Valsartan—coronary artery disease	0.000312	0.00155	CcSEcCtD
Ergonovine—Lisuride—HTR2A—coronary artery disease	0.000312	0.0696	CrCbGaD
Ergonovine—Muscle spasms—Ramipril—coronary artery disease	0.000311	0.00155	CcSEcCtD
Ergonovine—Dyspnoea—Telmisartan—coronary artery disease	0.00031	0.00154	CcSEcCtD
Ergonovine—Gastrointestinal pain—Olmesartan—coronary artery disease	0.00031	0.00154	CcSEcCtD
Ergonovine—Hyperhidrosis—Furosemide—coronary artery disease	0.000309	0.00154	CcSEcCtD
Ergonovine—Hypotension—Perindopril—coronary artery disease	0.000307	0.00153	CcSEcCtD
Ergonovine—Shock—Losartan—coronary artery disease	0.000303	0.00151	CcSEcCtD
Ergonovine—Gastrointestinal pain—Niacin—coronary artery disease	0.000303	0.00151	CcSEcCtD
Ergonovine—Nausea—Rosuvastatin—coronary artery disease	0.000303	0.0015	CcSEcCtD
Ergonovine—Diarrhoea—Fenofibrate—coronary artery disease	0.000302	0.0015	CcSEcCtD
Ergonovine—Dyspnoea—Captopril—coronary artery disease	0.000302	0.0015	CcSEcCtD
Ergonovine—Abdominal pain—Valsartan—coronary artery disease	0.000301	0.0015	CcSEcCtD
Ergonovine—Abdominal pain—Olmesartan—coronary artery disease	0.0003	0.00149	CcSEcCtD
Ergonovine—Ergotamine—HTR2A—coronary artery disease	0.000299	0.0668	CrCbGaD
Ergonovine—Hypotension—Furosemide—coronary artery disease	0.000299	0.00149	CcSEcCtD
Ergonovine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000298	0.00148	CcSEcCtD
Ergonovine—Hyperhidrosis—Losartan—coronary artery disease	0.000298	0.00148	CcSEcCtD
Ergonovine—Diarrhoea—Clopidogrel—coronary artery disease	0.000297	0.00148	CcSEcCtD
Ergonovine—Diarrhoea—Lovastatin—coronary artery disease	0.000295	0.00147	CcSEcCtD
Ergonovine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000294	0.00146	CcSEcCtD
Ergonovine—Dyspnoea—Perindopril—coronary artery disease	0.000293	0.00146	CcSEcCtD
Ergonovine—Abdominal pain—Niacin—coronary artery disease	0.000293	0.00146	CcSEcCtD
Ergonovine—Dizziness—Fenofibrate—coronary artery disease	0.000292	0.00145	CcSEcCtD
Ergonovine—Vertigo—Ramipril—coronary artery disease	0.000291	0.00145	CcSEcCtD
Ergonovine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.00029	0.00144	CcSEcCtD
Ergonovine—Diarrhoea—Ezetimibe—coronary artery disease	0.00029	0.00144	CcSEcCtD
Ergonovine—Bromocriptine—HTR2A—coronary artery disease	0.000289	0.0645	CrCbGaD
Ergonovine—Gastrointestinal pain—Enalapril—coronary artery disease	0.000289	0.00144	CcSEcCtD
Ergonovine—Abdominal pain—Pravastatin—coronary artery disease	0.000289	0.00143	CcSEcCtD
Ergonovine—Hypotension—Losartan—coronary artery disease	0.000288	0.00143	CcSEcCtD
Ergonovine—Dizziness—Clopidogrel—coronary artery disease	0.000287	0.00143	CcSEcCtD
Ergonovine—Palpitations—Ramipril—coronary artery disease	0.000286	0.00142	CcSEcCtD
Ergonovine—Dizziness—Lovastatin—coronary artery disease	0.000285	0.00142	CcSEcCtD
Ergonovine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000285	0.00142	CcSEcCtD
Ergonovine—Vertigo—Timolol—coronary artery disease	0.000285	0.00142	CcSEcCtD
Ergonovine—Diarrhoea—Eplerenone—coronary artery disease	0.000284	0.00141	CcSEcCtD
Ergonovine—Muscle spasms—Lisinopril—coronary artery disease	0.000282	0.0014	CcSEcCtD
Ergonovine—Vomiting—Fenofibrate—coronary artery disease	0.000281	0.0014	CcSEcCtD
Ergonovine—Abdominal pain—Trandolapril—coronary artery disease	0.00028	0.00139	CcSEcCtD
Ergonovine—Dizziness—Ezetimibe—coronary artery disease	0.00028	0.00139	CcSEcCtD
Ergonovine—Palpitations—Timolol—coronary artery disease	0.00028	0.00139	CcSEcCtD
Ergonovine—Abdominal pain—Enalapril—coronary artery disease	0.000279	0.00139	CcSEcCtD
Ergonovine—Headache—Fenofibrate—coronary artery disease	0.000277	0.00138	CcSEcCtD
Ergonovine—Gastrointestinal pain—Captopril—coronary artery disease	0.000277	0.00138	CcSEcCtD
Ergonovine—Vomiting—Clopidogrel—coronary artery disease	0.000276	0.00137	CcSEcCtD
Ergonovine—Diarrhoea—Simvastatin—coronary artery disease	0.000276	0.00137	CcSEcCtD
Ergonovine—Chest pain—Ramipril—coronary artery disease	0.000276	0.00137	CcSEcCtD
Ergonovine—Abdominal pain—Telmisartan—coronary artery disease	0.000275	0.00137	CcSEcCtD
Ergonovine—Dyspnoea—Losartan—coronary artery disease	0.000275	0.00137	CcSEcCtD
Ergonovine—Vomiting—Lovastatin—coronary artery disease	0.000274	0.00136	CcSEcCtD
Ergonovine—Dizziness—Eplerenone—coronary artery disease	0.000274	0.00136	CcSEcCtD
Ergonovine—Hypertension—Timolol—coronary artery disease	0.000273	0.00136	CcSEcCtD
Ergonovine—Headache—Clopidogrel—coronary artery disease	0.000272	0.00135	CcSEcCtD
Ergonovine—Headache—Lovastatin—coronary artery disease	0.00027	0.00134	CcSEcCtD
Ergonovine—Chest pain—Timolol—coronary artery disease	0.00027	0.00134	CcSEcCtD
Ergonovine—Vomiting—Ezetimibe—coronary artery disease	0.000269	0.00134	CcSEcCtD
Ergonovine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000269	0.00134	CcSEcCtD
Ergonovine—Abdominal pain—Captopril—coronary artery disease	0.000268	0.00133	CcSEcCtD
Ergonovine—Dizziness—Simvastatin—coronary artery disease	0.000267	0.00133	CcSEcCtD
Ergonovine—Headache—Ezetimibe—coronary artery disease	0.000265	0.00132	CcSEcCtD
Ergonovine—Vertigo—Lisinopril—coronary artery disease	0.000264	0.00131	CcSEcCtD
Ergonovine—Vomiting—Eplerenone—coronary artery disease	0.000263	0.00131	CcSEcCtD
Ergonovine—Nausea—Fenofibrate—coronary artery disease	0.000263	0.00131	CcSEcCtD
Ergonovine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000261	0.0013	CcSEcCtD
Ergonovine—Diarrhoea—Valsartan—coronary artery disease	0.000261	0.0013	CcSEcCtD
Ergonovine—Shock—Ramipril—coronary artery disease	0.00026	0.00129	CcSEcCtD
Ergonovine—Abdominal pain—Perindopril—coronary artery disease	0.00026	0.00129	CcSEcCtD
Ergonovine—Palpitations—Lisinopril—coronary artery disease	0.00026	0.00129	CcSEcCtD
Ergonovine—Diarrhoea—Olmesartan—coronary artery disease	0.00026	0.00129	CcSEcCtD
Ergonovine—Headache—Eplerenone—coronary artery disease	0.00026	0.00129	CcSEcCtD
Ergonovine—Nausea—Clopidogrel—coronary artery disease	0.000258	0.00128	CcSEcCtD
Ergonovine—Vomiting—Simvastatin—coronary artery disease	0.000257	0.00128	CcSEcCtD
Ergonovine—Nausea—Lovastatin—coronary artery disease	0.000256	0.00127	CcSEcCtD
Ergonovine—Hyperhidrosis—Ramipril—coronary artery disease	0.000256	0.00127	CcSEcCtD
Ergonovine—Shock—Timolol—coronary artery disease	0.000254	0.00126	CcSEcCtD
Ergonovine—Diarrhoea—Niacin—coronary artery disease	0.000254	0.00126	CcSEcCtD
Ergonovine—Headache—Simvastatin—coronary artery disease	0.000253	0.00126	CcSEcCtD
Ergonovine—Abdominal pain—Furosemide—coronary artery disease	0.000253	0.00126	CcSEcCtD
Ergonovine—Gastrointestinal pain—Losartan—coronary artery disease	0.000252	0.00125	CcSEcCtD
Ergonovine—Dizziness—Valsartan—coronary artery disease	0.000252	0.00125	CcSEcCtD
Ergonovine—Nausea—Ezetimibe—coronary artery disease	0.000251	0.00125	CcSEcCtD
Ergonovine—Dizziness—Olmesartan—coronary artery disease	0.000251	0.00125	CcSEcCtD
Ergonovine—Chest pain—Lisinopril—coronary artery disease	0.00025	0.00124	CcSEcCtD
Ergonovine—Hyperhidrosis—Timolol—coronary artery disease	0.00025	0.00124	CcSEcCtD
Ergonovine—Diarrhoea—Pravastatin—coronary artery disease	0.00025	0.00124	CcSEcCtD
Ergonovine—Hypotension—Ramipril—coronary artery disease	0.000247	0.00123	CcSEcCtD
Ergonovine—Nausea—Eplerenone—coronary artery disease	0.000246	0.00122	CcSEcCtD
Ergonovine—Dizziness—Niacin—coronary artery disease	0.000245	0.00122	CcSEcCtD
Ergonovine—Abdominal pain—Losartan—coronary artery disease	0.000244	0.00121	CcSEcCtD
Ergonovine—Diarrhoea—Trandolapril—coronary artery disease	0.000243	0.00121	CcSEcCtD
Ergonovine—Vomiting—Valsartan—coronary artery disease	0.000242	0.00121	CcSEcCtD
Ergonovine—Diarrhoea—Enalapril—coronary artery disease	0.000242	0.0012	CcSEcCtD
Ergonovine—Hypotension—Timolol—coronary artery disease	0.000242	0.0012	CcSEcCtD
Ergonovine—Dizziness—Pravastatin—coronary artery disease	0.000241	0.0012	CcSEcCtD
Ergonovine—Vomiting—Olmesartan—coronary artery disease	0.000241	0.0012	CcSEcCtD
Ergonovine—Nausea—Simvastatin—coronary artery disease	0.00024	0.00119	CcSEcCtD
Ergonovine—Headache—Valsartan—coronary artery disease	0.000239	0.00119	CcSEcCtD
Ergonovine—Diarrhoea—Telmisartan—coronary artery disease	0.000238	0.00118	CcSEcCtD
Ergonovine—Headache—Olmesartan—coronary artery disease	0.000238	0.00118	CcSEcCtD
Ergonovine—Shock—Lisinopril—coronary artery disease	0.000236	0.00117	CcSEcCtD
Ergonovine—Dyspnoea—Ramipril—coronary artery disease	0.000236	0.00117	CcSEcCtD
Ergonovine—Vomiting—Niacin—coronary artery disease	0.000236	0.00117	CcSEcCtD
Ergonovine—Dizziness—Trandolapril—coronary artery disease	0.000234	0.00117	CcSEcCtD
Ergonovine—Dizziness—Enalapril—coronary artery disease	0.000233	0.00116	CcSEcCtD
Ergonovine—Headache—Niacin—coronary artery disease	0.000232	0.00115	CcSEcCtD
Ergonovine—Vomiting—Pravastatin—coronary artery disease	0.000232	0.00115	CcSEcCtD
Ergonovine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000232	0.00115	CcSEcCtD
Ergonovine—Diarrhoea—Captopril—coronary artery disease	0.000232	0.00115	CcSEcCtD
Ergonovine—Dyspnoea—Timolol—coronary artery disease	0.00023	0.00115	CcSEcCtD
Ergonovine—Dizziness—Telmisartan—coronary artery disease	0.00023	0.00115	CcSEcCtD
Ergonovine—Headache—Pravastatin—coronary artery disease	0.000229	0.00114	CcSEcCtD
Ergonovine—Nausea—Valsartan—coronary artery disease	0.000226	0.00113	CcSEcCtD
Ergonovine—Nausea—Olmesartan—coronary artery disease	0.000225	0.00112	CcSEcCtD
Ergonovine—Vomiting—Trandolapril—coronary artery disease	0.000225	0.00112	CcSEcCtD
Ergonovine—Diarrhoea—Perindopril—coronary artery disease	0.000225	0.00112	CcSEcCtD
Ergonovine—Vomiting—Enalapril—coronary artery disease	0.000224	0.00112	CcSEcCtD
Ergonovine—Hypotension—Lisinopril—coronary artery disease	0.000224	0.00111	CcSEcCtD
Ergonovine—Dizziness—Captopril—coronary artery disease	0.000224	0.00111	CcSEcCtD
Ergonovine—Headache—Trandolapril—coronary artery disease	0.000222	0.0011	CcSEcCtD
Ergonovine—Vomiting—Telmisartan—coronary artery disease	0.000221	0.0011	CcSEcCtD
Ergonovine—Headache—Enalapril—coronary artery disease	0.000221	0.0011	CcSEcCtD
Ergonovine—Nausea—Niacin—coronary artery disease	0.00022	0.00109	CcSEcCtD
Ergonovine—Diarrhoea—Furosemide—coronary artery disease	0.000219	0.00109	CcSEcCtD
Ergonovine—Headache—Telmisartan—coronary artery disease	0.000218	0.00108	CcSEcCtD
Ergonovine—Dizziness—Perindopril—coronary artery disease	0.000217	0.00108	CcSEcCtD
Ergonovine—Nausea—Pravastatin—coronary artery disease	0.000217	0.00108	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000216	0.00108	CcSEcCtD
Ergonovine—Vomiting—Captopril—coronary artery disease	0.000215	0.00107	CcSEcCtD
Ergonovine—Dyspnoea—Lisinopril—coronary artery disease	0.000214	0.00106	CcSEcCtD
Ergonovine—Headache—Captopril—coronary artery disease	0.000212	0.00105	CcSEcCtD
Ergonovine—Gastrointestinal pain—Timolol—coronary artery disease	0.000211	0.00105	CcSEcCtD
Ergonovine—Dizziness—Furosemide—coronary artery disease	0.000211	0.00105	CcSEcCtD
Ergonovine—Diarrhoea—Losartan—coronary artery disease	0.000211	0.00105	CcSEcCtD
Ergonovine—Nausea—Trandolapril—coronary artery disease	0.000211	0.00105	CcSEcCtD
Ergonovine—Nausea—Enalapril—coronary artery disease	0.00021	0.00104	CcSEcCtD
Ergonovine—Vomiting—Perindopril—coronary artery disease	0.000209	0.00104	CcSEcCtD
Ergonovine—Abdominal pain—Ramipril—coronary artery disease	0.000209	0.00104	CcSEcCtD
Ergonovine—Nausea—Telmisartan—coronary artery disease	0.000207	0.00103	CcSEcCtD
Ergonovine—Headache—Perindopril—coronary artery disease	0.000206	0.00102	CcSEcCtD
Ergonovine—Abdominal pain—Timolol—coronary artery disease	0.000204	0.00102	CcSEcCtD
Ergonovine—Dizziness—Losartan—coronary artery disease	0.000204	0.00101	CcSEcCtD
Ergonovine—Vomiting—Furosemide—coronary artery disease	0.000203	0.00101	CcSEcCtD
Ergonovine—Nausea—Captopril—coronary artery disease	0.000201	0.001	CcSEcCtD
Ergonovine—Headache—Furosemide—coronary artery disease	0.0002	0.000996	CcSEcCtD
Ergonovine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000196	0.000975	CcSEcCtD
Ergonovine—Vomiting—Losartan—coronary artery disease	0.000196	0.000975	CcSEcCtD
Ergonovine—Nausea—Perindopril—coronary artery disease	0.000195	0.000971	CcSEcCtD
Ergonovine—Headache—Losartan—coronary artery disease	0.000193	0.000961	CcSEcCtD
Ergonovine—Nausea—Furosemide—coronary artery disease	0.00019	0.000944	CcSEcCtD
Ergonovine—Abdominal pain—Lisinopril—coronary artery disease	0.00019	0.000943	CcSEcCtD
Ergonovine—Nausea—Losartan—coronary artery disease	0.000183	0.000911	CcSEcCtD
Ergonovine—Diarrhoea—Ramipril—coronary artery disease	0.000181	0.0009	CcSEcCtD
Ergonovine—Diarrhoea—Timolol—coronary artery disease	0.000177	0.000879	CcSEcCtD
Ergonovine—Dizziness—Ramipril—coronary artery disease	0.000175	0.000869	CcSEcCtD
Ergonovine—Dizziness—Timolol—coronary artery disease	0.000171	0.00085	CcSEcCtD
Ergonovine—Vomiting—Ramipril—coronary artery disease	0.000168	0.000836	CcSEcCtD
Ergonovine—Headache—Ramipril—coronary artery disease	0.000166	0.000824	CcSEcCtD
Ergonovine—Vomiting—Timolol—coronary artery disease	0.000164	0.000817	CcSEcCtD
Ergonovine—Diarrhoea—Lisinopril—coronary artery disease	0.000164	0.000816	CcSEcCtD
Ergonovine—Headache—Timolol—coronary artery disease	0.000162	0.000805	CcSEcCtD
Ergonovine—Dizziness—Lisinopril—coronary artery disease	0.000159	0.000789	CcSEcCtD
Ergonovine—Nausea—Ramipril—coronary artery disease	0.000157	0.000781	CcSEcCtD
Ergonovine—Nausea—Timolol—coronary artery disease	0.000154	0.000763	CcSEcCtD
Ergonovine—Vomiting—Lisinopril—coronary artery disease	0.000152	0.000758	CcSEcCtD
Ergonovine—Headache—Lisinopril—coronary artery disease	0.00015	0.000747	CcSEcCtD
Ergonovine—Nausea—Lisinopril—coronary artery disease	0.000142	0.000708	CcSEcCtD
Ergonovine—HTR1E—GPCR downstream signaling—AKT1—coronary artery disease	1.11e-05	9.45e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOC3—coronary artery disease	1.11e-05	9.4e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CASP3—coronary artery disease	1.1e-05	9.36e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LDLR—coronary artery disease	1.1e-05	9.34e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—coronary artery disease	1.09e-05	9.3e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.09e-05	9.28e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOB—coronary artery disease	1.09e-05	9.25e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC9A1—coronary artery disease	1.09e-05	9.23e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTT1—coronary artery disease	1.09e-05	9.23e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	1.08e-05	9.21e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	1.08e-05	9.18e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—coronary artery disease	1.08e-05	9.17e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	1.08e-05	9.15e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	1.08e-05	9.15e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	1.07e-05	9.13e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—JAK2—coronary artery disease	1.07e-05	9.13e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CETP—coronary artery disease	1.07e-05	9.12e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GCLC—coronary artery disease	1.07e-05	9.12e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCND1—coronary artery disease	1.07e-05	9.11e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EDN1—coronary artery disease	1.07e-05	9.1e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LCAT—coronary artery disease	1.07e-05	9.1e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.07e-05	9.1e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL5—coronary artery disease	1.06e-05	9.03e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SDC1—coronary artery disease	1.06e-05	9.02e-05	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	1.05e-05	8.96e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	1.05e-05	8.96e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA4—coronary artery disease	1.05e-05	8.93e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	1.05e-05	8.93e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	1.05e-05	8.92e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CSF2—coronary artery disease	1.05e-05	8.9e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF1—coronary artery disease	1.05e-05	8.9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLG—coronary artery disease	1.05e-05	8.9e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—coronary artery disease	1.04e-05	8.85e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LPL—coronary artery disease	1.04e-05	8.83e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RPS6KB1—coronary artery disease	1.03e-05	8.75e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MEF2C—coronary artery disease	1.03e-05	8.75e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	1.02e-05	8.66e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.01e-05	8.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCLM—coronary artery disease	1.01e-05	8.62e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—coronary artery disease	1.01e-05	8.58e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	1.01e-05	8.55e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	1.01e-05	8.54e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ITGB3—coronary artery disease	1e-05	8.53e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	1e-05	8.53e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PSMA6—coronary artery disease	1e-05	8.52e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PSMB5—coronary artery disease	1e-05	8.52e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—S100B—coronary artery disease	1e-05	8.51e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	9.91e-06	8.43e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	9.83e-06	8.35e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	9.83e-06	8.35e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—coronary artery disease	9.8e-06	8.33e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	9.79e-06	8.33e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	9.79e-06	8.33e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CTGF—coronary artery disease	9.79e-06	8.33e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PPP2CA—coronary artery disease	9.75e-06	8.29e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMGCR—coronary artery disease	9.71e-06	8.25e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GOT2—coronary artery disease	9.71e-06	8.25e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	9.68e-06	8.23e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	9.57e-06	8.14e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PRKCD—coronary artery disease	9.57e-06	8.14e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	9.57e-06	8.14e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HADH—coronary artery disease	9.54e-06	8.11e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ARNTL—coronary artery disease	9.54e-06	8.11e-05	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	9.51e-06	8.09e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HTR2A—coronary artery disease	9.37e-06	7.96e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—C3—coronary artery disease	9.35e-06	7.95e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—coronary artery disease	9.34e-06	7.94e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOB—coronary artery disease	9.25e-06	7.87e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	9.17e-06	7.8e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	9.13e-06	7.76e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	9.11e-06	7.74e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	9.04e-06	7.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA2—coronary artery disease	9.04e-06	7.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX2—coronary artery disease	9.04e-06	7.69e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	9.03e-06	7.68e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG5—coronary artery disease	8.93e-06	7.59e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	8.93e-06	7.59e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HK1—coronary artery disease	8.93e-06	7.59e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX4—coronary artery disease	8.93e-06	7.59e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PLCB1—coronary artery disease	8.92e-06	7.59e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HIF1A—coronary artery disease	8.92e-06	7.58e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	8.9e-06	7.57e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	8.9e-06	7.57e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AGT—coronary artery disease	8.89e-06	7.56e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LPL—coronary artery disease	8.83e-06	7.51e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HADHA—coronary artery disease	8.83e-06	7.5e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	8.76e-06	7.44e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	8.76e-06	7.44e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTA1—coronary artery disease	8.72e-06	7.42e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—coronary artery disease	8.71e-06	7.4e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOE—coronary artery disease	8.71e-06	7.4e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ABCA1—coronary artery disease	8.65e-06	7.35e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPA—coronary artery disease	8.63e-06	7.33e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOA1—coronary artery disease	8.61e-06	7.32e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—coronary artery disease	8.58e-06	7.29e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KDR—coronary artery disease	8.53e-06	7.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	8.53e-06	7.25e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK14—coronary artery disease	8.48e-06	7.21e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK1—coronary artery disease	8.41e-06	7.15e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GOT1—coronary artery disease	8.38e-06	7.12e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GGT1—coronary artery disease	8.38e-06	7.12e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLCB3—coronary artery disease	8.36e-06	7.1e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	8.33e-06	7.08e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ESR1—coronary artery disease	8.31e-06	7.07e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	8.29e-06	7.05e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA5—coronary artery disease	8.27e-06	7.03e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—F2—coronary artery disease	8.21e-06	6.98e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FN1—coronary artery disease	8.21e-06	6.98e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6ST—coronary artery disease	8.18e-06	6.95e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	8.14e-06	6.92e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKBIA—coronary artery disease	8.12e-06	6.9e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—P4HB—coronary artery disease	8.11e-06	6.9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	7.97e-06	6.77e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	7.96e-06	6.77e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—C3—coronary artery disease	7.95e-06	6.76e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KIT—coronary artery disease	7.86e-06	6.68e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	7.59e-06	6.45e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AGT—coronary artery disease	7.56e-06	6.42e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GSK3B—coronary artery disease	7.54e-06	6.41e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTP1—coronary artery disease	7.53e-06	6.4e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—VCAN—coronary artery disease	7.5e-06	6.38e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—POMC—coronary artery disease	7.48e-06	6.36e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CREB1—coronary artery disease	7.48e-06	6.36e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	7.46e-06	6.34e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALDOA—coronary artery disease	7.45e-06	6.33e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMOX1—coronary artery disease	7.42e-06	6.31e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOE—coronary artery disease	7.41e-06	6.3e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—coronary artery disease	7.41e-06	6.3e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CAT—coronary artery disease	7.32e-06	6.23e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL2—coronary artery disease	7.32e-06	6.22e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	7.32e-06	6.22e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CA—coronary artery disease	7.3e-06	6.2e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6R—coronary artery disease	7.3e-06	6.2e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KDR—coronary artery disease	7.25e-06	6.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—DCN—coronary artery disease	7.23e-06	6.15e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	7.21e-06	6.13e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—coronary artery disease	7.2e-06	6.12e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	7.16e-06	6.09e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOB—coronary artery disease	7.11e-06	6.04e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	7.07e-06	6.01e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.03e-06	5.98e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FN1—coronary artery disease	6.98e-06	5.94e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—F2—coronary artery disease	6.98e-06	5.94e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	6.96e-06	5.91e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—coronary artery disease	6.92e-06	5.88e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	6.9e-06	5.87e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LIPC—coronary artery disease	6.85e-06	5.83e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HBA1—coronary artery disease	6.85e-06	5.83e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	6.85e-06	5.83e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	6.85e-06	5.83e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	6.84e-06	5.82e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	6.83e-06	5.81e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOC3—coronary artery disease	6.81e-06	5.79e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LPL—coronary artery disease	6.79e-06	5.77e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LDLR—coronary artery disease	6.77e-06	5.75e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	6.69e-06	5.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTT1—coronary artery disease	6.69e-06	5.69e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KIT—coronary artery disease	6.68e-06	5.68e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPX1—coronary artery disease	6.62e-06	5.63e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	6.62e-06	5.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCLC—coronary artery disease	6.61e-06	5.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CETP—coronary artery disease	6.61e-06	5.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SDC1—coronary artery disease	6.54e-06	5.56e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	6.52e-06	5.55e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—coronary artery disease	6.46e-06	5.49e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CD36—coronary artery disease	6.45e-06	5.48e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	6.41e-06	5.45e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPP2CA—coronary artery disease	6.37e-06	5.41e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—POMC—coronary artery disease	6.36e-06	5.41e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	6.36e-06	5.41e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	6.34e-06	5.39e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	6.22e-06	5.29e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	6.21e-06	5.28e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	6.21e-06	5.28e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.18e-06	5.25e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.18e-06	5.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	6.12e-06	5.2e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—coronary artery disease	6.11e-06	5.2e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	6.09e-06	5.18e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CTGF—coronary artery disease	6.03e-06	5.13e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.98e-06	5.08e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GOT2—coronary artery disease	5.98e-06	5.08e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—coronary artery disease	5.96e-06	5.07e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.82e-06	4.95e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	5.81e-06	4.94e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AGT—coronary artery disease	5.81e-06	4.94e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	5.79e-06	4.92e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOE—coronary artery disease	5.69e-06	4.84e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	5.63e-06	4.78e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOA1—coronary artery disease	5.62e-06	4.78e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	5.59e-06	4.75e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	5.55e-06	4.72e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	5.54e-06	4.71e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	5.5e-06	4.68e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.5e-06	4.67e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	5.39e-06	4.58e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	5.39e-06	4.58e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.33e-06	4.53e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	5.28e-06	4.49e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	5.23e-06	4.45e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GGT1—coronary artery disease	5.16e-06	4.39e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GOT1—coronary artery disease	5.16e-06	4.39e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	5.08e-06	4.32e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARG—coronary artery disease	4.96e-06	4.21e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	4.92e-06	4.18e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—POMC—coronary artery disease	4.89e-06	4.16e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	4.75e-06	4.04e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	4.71e-06	4e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	4.7e-06	4e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	4.68e-06	3.98e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.64e-06	3.94e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.59e-06	3.9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	4.58e-06	3.9e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.57e-06	3.89e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CAT—coronary artery disease	4.51e-06	3.84e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—coronary artery disease	4.46e-06	3.79e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	4.45e-06	3.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOB—coronary artery disease	4.38e-06	3.72e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	4.32e-06	3.67e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	4.31e-06	3.67e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NOS3—coronary artery disease	4.26e-06	3.62e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.26e-06	3.62e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	4.23e-06	3.6e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPL—coronary artery disease	4.18e-06	3.56e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX1—coronary artery disease	4.08e-06	3.47e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	4e-06	3.4e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CD36—coronary artery disease	3.97e-06	3.38e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.92e-06	3.34e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—coronary artery disease	3.9e-06	3.31e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.77e-06	3.2e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	3.67e-06	3.12e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	3.67e-06	3.12e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	3.6e-06	3.06e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AGT—coronary artery disease	3.58e-06	3.04e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOE—coronary artery disease	3.51e-06	2.98e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA1—coronary artery disease	3.47e-06	2.95e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—coronary artery disease	3.25e-06	2.76e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	3.12e-06	2.65e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARG—coronary artery disease	3.05e-06	2.6e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—POMC—coronary artery disease	3.01e-06	2.56e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	3e-06	2.55e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	2.76e-06	2.35e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—coronary artery disease	2.75e-06	2.33e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NOS3—coronary artery disease	2.63e-06	2.23e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	2.55e-06	2.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.4e-06	2.04e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.4e-06	2.04e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—coronary artery disease	1.96e-06	1.67e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.48e-06	1.26e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.21e-06	1.03e-05	CbGpPWpGaD
